Pharmacological modulation of LPS-induced MIP-1α production by peripheral blood mononuclear cells

Pharmacology

Volumn 56, Issue 5, 1998, Pages 230-236

  Kimata, Masahiro ^a   Shichijo, Michitaka ^a   Daikoku, Michio ^b   Inagaki, Naoki ^a   Mori, Hiroshi ^a   Nagai, Hiroichi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b National Hospital Organization   (Japan)

Author keywords

Anti asthmatic drugs; Macrophage inflammatory protein 1 ; Peripheral blood mononuclear cells

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLOHEXIMIDE; DACTINOMYCIN; GLUCOCORTICOID; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM;

ARTICLE; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL;

ADRENERGIC BETA-AGONISTS; ANTI-ASTHMATIC AGENTS; BUCLADESINE; ENDOTOXINS; ESCHERICHIA COLI; GLUCOCORTICOIDS; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGE INFLAMMATORY PROTEIN-1; MONOCYTES; PHOSPHODIESTERASE INHIBITORS; PROTEIN SYNTHESIS INHIBITORS;

EID: 0031944004     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028202     Document Type: Article

References (18)

1. Baggiolini M, Dahinden CA: CC chemokines in allergic inflammation. Immunol Today 1994;15:127-133.
2. Wolpe SD, Davatelis G, Sherry B, Beutler B, Hesse DG, Nguyen HT, Moldawer LL, Nathan CF, Lowry SF, Cerami A: Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med 1988;167:570-581.
3. Shanley TP, Schamal H, Friedl HP, Jones ML, Ward PA: Role of macrophage inflammatory protein-1α (MIP-1α) in acute lung injury in rats. J Immunol 1995;154:4793-4802.
4. Lukacs NW, Strieter RM, Shaklee CL, Chensue SW, Kunkel SL: Macrophage inflammatory protein-α influences eosinophil recruitment in antigen-specific airway inflammation. Eur J Immunol 1995;25:245-251.
5. Taub DD, Conlon K, Lioyd AR, Oppenheim JJ, Kelvin DJ: Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1α and MIP-1β. Science 1993;260: 355-358.
6. Taub D, Datsych J, Inamura N, Upton J, Kelvin D, Metcalfe D, Oppenheim J: Bone marrow-derived murine mast cells migrate, but do not degranulate, in response to chemokines. J Immunol 1995; 154:2393-2402.
7. Alam R, Forsythe PA, Stafford S, Lett-Brown MA, Grant JA: Macrophage inflammatory protein-1α activates basophils and mast cells. J Exp Med 1992;176:781-786.
8. Reed CE: The importance of eosinophils in the immunology of asthma and allergic disease. Ann Allergy 1994;72:376-380.
9. Alam R, York J, Boyars M, Stafford S, Grant JA, Lee J, Forsythe P, Sim T, Ida N: Increased MCP-1, RANTES, and MIP-1α in bronchoalveolar lavage fluid of allergic asthmatic patients. Am J Respir Crit Care Med 1996;153:1398-1404.
10. Kurashima K, Mukaida N, Fujimura M, Schroder JM, Matsuda T, Matsushima K: Increase of chemokine levels in sputum precedes exacerbation of acute asthma attacks. J Leukoc Biol 1996;59:313-316.
11. Yarnall P, Taylor JD, Furdon PJ: Differential regulation of human monocyte-derived TNF-α and IL-1β by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors. J Pharmacol Exp Ther 1995;272:1313-1320.
12. Sinha B, Semmier J, Eisenhut T, Eigler A, Endres S: Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids. Eur J Immunol 1995;25:147-153.
13. Kyan-Aung U, Hascard DO, Poston RN, Thornhill MH, Lee TH: Endothelia leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. J Immunol 1991;146:521-528.
14. Wellicome SM, Thonhill MH, Pitzalis C, Thomas DS, Lanchbury JSS, Panayi GS, Haskard DO: A monoclonal antibody that detects a novel antigen on endothelial cells that induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J Immunol 1990; 144:2558-2565.
15. Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA: RANTES and macrophage inflammatory protein-1α induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992;176:1489-1495.
16. Verghese MW, McConnell RT, Strickland AB, Gooding RC, Stimpson SA, Yarnall DP, Taylor JD, Furdon PJ: Differential regulation of human monocyte-derived TNF-α and IL-1β by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors. J Pharmacol Exp Ther 1995; 272:1313-1320.
17. Prabhakar U, Lipshutz D, Bartus JO, Slivjak MJ, Smith EF, Lee JC, Esser KM: Characterization of cAMP-dependent inhibition of LPS-induced TNF-α production by roliplam, a specific phosphodiesterase IV (PDE-IV) inhibitor. Int J Immunopharmacol 1994;16:805-816.
18. Manning CD, McLaughlin MM, Livi GP, Cieslinski LB, Torphy TJ, Barnette MS: Prolonged β adrenoreceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phospho-2diesterase 4A and 4B. J Pharmacol Exp Ther 1996;276:810-818.